Nancy Kercher, independent biotech professional, regulatory affairs
Anne Kerner, senior consultant, DKPierce & Associates
Randal Ketchem, principal scientist, Amgen
Yuni Kim, independent clinical research professional
Barrett Kimball Barnett, merchandise communications program manager, REI
Susan Kipper, manager of clinical safety, Dendreon
Michael Kirschner, attorney, Hillis, Clark, Martin & Peterson
Michael Kleinberg, independent biotechnology professional
Ralph Klinke, principal consultant, BioFios Consulting
Gerald Kolaja, consultant, Baloa BioConsulting [Added: 3:30 pm, 1/7/11]
Diane Kolb (formerly DiMaggio), faculty recruitment manager and assistant to the chair, Department of Biostatistics, Vanderbilt University School of Medicine [Added: 8:55 am, 1/4/11]
John Kollins, managing director, Locust Walk Partners
Ann Kopischke, product manager, ZymoGenetics
Michael Kranda, chairman, Cardero Therapeutics
Carol Krantz, director of regulatory affairs, Amgen
Keith LaChappelle, facilities manager, Dendreon [Added: 3 pm, 1/13/11]
Tom LaGrandeur, patent attorney, Patent Networks Law Group [Updated: 10:30 am, 12/30/11]
Stacey Lange (King), Realtor, Windermere Real Estate
Randy Lawson, president, Integrity Medical Sales
Mark Leahy, cleantech entrepreneur
Wylene Lengel, director of life sciences, Clarkston Consulting
Rachel Lenington, senior program officer, infectious diseases, global health, Bill & Melinda Gates Foundation [Added: 11:45 am, 1/5/11]
David Liebowitz, chief scientific and medical officer, Vivaldi Biosciences
Mike Liptack, software manager, Microsoft [Added: 9:45 am, 1/6/11]
Sarah Litchfield, human resources manager, Amgen [Added: 2:40 pm, 1/3/11]
Lori Lodzinski, biotechnology consultant
Tim Lofton, senior associate scientist, Amgen [Added: 4:40 pm, 1/4/11]
Monica L’Tainen, senior medical science liaison, Cell Therapeutics
Cheryl Lubbert, president, Health Advocacy Strategies
Steve Lupton, biopharmaceutical business development
Stewart Lyman, owner, Lyman Biopharma Consulting
Steve Malaska, vice president, director of biotech prosecution, Intellectual Ventures
Charlie Maliszewski, environmental education/advocacy
David Mann, former board member, Trubion Pharmaceuticals (now Emergent Biosolutions)
Carl March, biotechnology consultant
Andy Marie, senior engineering technician, CMC Icos Biologics
